Instruments

Name Stock exchange Average volume Price Type
RAPHAËL MICHEL MLRAM

Euronext Paris

0 13 EUR Stock Raphaël Michel Stock

News (356)

Revvity : Notice of Annual Meeting and Proxy Statement 2024 PU
Legend Biotech Reports First Quarter 2023 Results and Recent Highlights BU
REVVITY, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Legend Biotech Establishes Strategic Advisory Board BU
Legend Biotech Establishes Strategic Advisory Board CI
Transcript : Zai Lab Limited, Q4 2022 Earnings Call, Mar 02, 2023
ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates GL
Zai Lab Limited Announces Executive Appointments CI
ZAI LAB LTD : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
Zai Lab Appoints Michel Vounatsos To Its Board of Directors GL
Zai Lab Appoints Michel Vounatsos To Its Board of Directors GL
Zai Lab Limited Appoints Michel Vounatsos to the Board of Directors CI
Biogen splits R&D division ahead of key decision on Alzheimer's drug RE
Landmark Alzheimer's drug slows down disease in early stages AQ
Biogen tabs veteran pharma leader Viehbacher as next CEO AQ
Biogen names Christopher Viehbacher as CEO RE
Biogen Names Christopher Viehbacher President and Chief Executive Officer GL
Biogen Names Christopher Viehbacher President and Chief Executive Officer AQ
Biogen : Names Christopher Viehbacher President and Chief Executive Officer - Form 8-K PU
BIOGEN INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Biogen Inc. Announces Executive Changes CI
Biogen Inc. Announces Board and Executive Changes CI
Transcript : Biogen Inc., Q3 2022 Earnings Call, Oct 25, 2022
Biogen confident in Alzheimer's drug ahead of rivals' data RE
Biogen : Q3 2022 Biogen Earnings Presentation PU
Biogen : Reports Q3 2022 Earnings PU
Biogen : Reports Third Quarter 2022 Results - Form 8-K PU
Biogen : Reports Third Quarter 2022 Results PU
Former J&J executive emerges as front-runner for Biogen top job - STAT News RE
EISAI - LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE AQ
Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint AQ
Eisai : LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE PU
EISAI PRESENTS NEW FINDINGS ON LECANEMAB'S INVESTIGATIONAL SUBCUTANEOUS FORMULATION AND MODELING SIMULATION OF APOE4 GENOTYPE ON ARIA-E INCIDENCE AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2022 PR
Biogen : Reports Second Quarter 2022 Results - Form 8-K/A PU
Biogen chops expenses in Q2, raises 2022 profit forecast AQ
Transcript : Biogen Inc., Q2 2022 Earnings Call, Jul 20, 2022
Biogen : Reports Second Quarter 2022 Results 582.7 KB PU
Biogen : Reports Second Quarter 2022 Results PU
Biogen : Reports Second Quarter 2022 Results - Form 8-K PU
Biogen : Q2 2022 Biogen Earnings Presentation PU
Biogen : Reports Q2 2022 Earnings PU
Eisai Co., Ltd. - THE U.S. FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI'S BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY AQ
U.S. FDA Accepts and Grants Priority Review for Eisai's Biologics License Application of Lecanemab AQ
THE U.S. FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI'S BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY PR
1234NextSee all

Companies (10)

MICHELL Y CÍA. S.A. 68 M $
Logo Michell y Cía. S.A.

Michell y Cia SA is a Peru-based company primarily engaged in the textile industry. The Company specializes in the production, distribution, sale and export of alpaca yarns, wool and specialty blends used for hand knitting and machine knitting and weaving ...

RAPHAËL MICHEL 9 M $
Logo Raphaël Michel

Raphael Michel SA is a France-based company engaged in the selling and marketing of wine. The Company selects and purchases red, white and rose wines from cooperatives and winegrowers, which are then stored, filtered and aged in the Company's own cellars, ...

RETAIL FOOD GROUP LIMITED 113 M $
Logo Retail Food Group Limited

Retail Food Group Limited is an Australia-based food and beverage company. It is multi-brand retail food franchise owner, and a roaster and supplier of coffee products. It owns intellectual property of the Donut King, Brumby’s Bakery, Michel’s Patisse ...

SIMONDS FARSONS CISK PLC 264 M $
Logo Simonds Farsons Cisk plc

Simonds Farsons Cisk plc is a Malta-based holding company. The Company is engaged in manufacturing of branded beers and beverages, including a Cisk range of beers, Blue Label Amber Ale, the Kinnie range of soft drinks and San Michel table water among othe ...

ZINCCORP RESOURCES INC. 20 $
Logo Zinccorp Resources Inc.

Zinccorp Resources Inc (Zinccorp) is a Canada-based junior mineral exploration Company. The Company is engaged in the acquisition, exploration, and development of mineral properties. Its projects include Liberty Fork Project, Stewart River Project (ET cla ...

SILVER RANGE RESOURCES LTD. 7 M $
Logo Silver Range Resources Ltd.

Silver Range Resources Ltd. is a Canada-based mineral exploration company. The Company’s mineral property interests include various mineral properties located in the Yukon Territory, Northwest Territories and Nunavut in Canada and in Nevada, United Stat ...

TAYA CO.,LTD. 12 M $
Logo TAYA Co.,Ltd.

TAYA Co., Ltd. is mainly engaged in the operation of beauty salons. The Company mainly offers beauty services, such as perm, cut and hair coloring services. In addition, the Company is also engaged in the sale of hair care products. The Company operates i ...

YGM TRADING LIMITED 20 M $
Logo YGM Trading Limited

YGM Trading Limited is a Hong Kong-based investment holding company principally engaged in garment, trademark, printing and property businesses. The Company operates through four segments. Sales of Garments segment is engaged in the manufacture, retailing ...

NOUVEAU MONDE GRAPHITE INC. 233 M $
Logo Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc. is a Canada-based company, which is specialized in the exploration, evaluation and development of mineral properties located in Quebec. It is focused on developing a fully integrated source of carbon-neutral battery anode mater ...

FOSSIL GROUP, INC. 69 M $
Logo Fossil Group, Inc.

Fossil Group, Inc. is a design, marketing and distribution company that specializes in consumer fashion accessories. The Company’s principal offerings include a line of men's and women's fashion traditional watches, smartwatches, jewelry, handbags, smal ...


Insiders

Picture Michel Vounatsos
Michel Vounatsos

Michel Vounatsos is on the board of PerkinElmer, Inc. (United States), L’Institut de RYthmologie et Modélisation Cardiaque and n-Lorem Foundation and Chief Executive Officer & Director at Biogen, Inc. In his past career he occupied the position of President-Primary Care & Customer Business Line at Merck & Co., Inc. Mr. Vounatsos received an MBA from École des Hautes Études Commerciales de Paris.








Picture Michel Côté
Michel Côté

Mr. Michel Côté is a Senior Partner at Novacap Industries, a Senior Partner at Novacap Management, Inc. and a Secretary, Treasurer & Director at Digico Fabrication Électronique, Inc. He is on the Board of Directors at Digico Fabrication Électronique, Inc. Mr. Côté was previously employed as a President by Hosted Data Transaction Solutions, Inc., a President by Dexit, Inc., a Senior Vice President- Partners & Products by Posera Ltd., a Vice President & General Manager by Posera, Inc., and a Principal by GHP Group, Inc. He received his undergraduate degree from the University of Montréal and an MBA from the University of Liege.

No results for this search